P-152 YI No Iron and No Anemia: Who Are These Crohn's Patients and What Is Their Evolution?

    loading  Checking for direct PDF access through Ovid



Despite many studies exist about anemia in Crohn's Disease (CD), information about iron-deficiency without anemia (IDWA) is still scarce. The aim of this study was to characterize CD patients who had IDWA, as well as their evolution during the follow-up.


CD patients who had at least one episode of IDWA between January of 2011 and December of 2014 were included in our study. Iron-deficiency was defined as serum ferritin <30 μg/L in the absence of inflammation or serum ferritin between 30 and 100 μg/L when inflammation was present. Besides characterization of patients' evolution during the follow-up, demographic and clinical differences between the 2 groups were also evaluated using the χ2 and the Fisher's Exact tests.


From the 136 patients with IDWA, 97 (71.3%) were women and the mean follow-up duration was 42 ± 16 months. Regarding the evolution, 43 patients (31.6%) developed anemia, 51 (37.5%) had recovery of the IDWA during the follow-up, 35 (25.7%) had persistent IDWA, and in 7 patients (5.2%) recurrence of IDWA was observed after an initial recovery. Only 8 patients (5.9%) received iron supplements for IDWA. There were no differences between the group with serum ferritin <30 μg/L and the group with serum ferritin between 30 and 100 μg/L concerning gender (P = 0.849), extension (P = 0.91) or behavior of disease (P = 0.056), age at the diagnosis (P = 0.401), perianal (P = 0.571) or upper gastrointestinal tract involvement (P = 0.749), family history of inflammatory bowel disease (P = 0.051) or smoking habits (P = 0.555). Despite the development of anemia did not differ significantly between the 2 groups (P = 0.957), recovery was significantly higher in patients with ferritin between 30 and 100 μg/L (P = 0.025).


Although IDWA is transient in about one third of patients with CD, another third of the patients will develop anemia during the follow-up. This result highlights the importance of investigation and follow-up of IDWA, particularly in patients with lower values of serum ferritin, in whom recovery is not so frequent.

Related Topics

    loading  Loading Related Articles